Modulation of radiation response by histone deacetylase inhibition

This publication has 28 references indexed in Scilit:

• Enhancement of Xenograft Tumor Radiosensitivity by the Histone Deacetylase Inhibitor MS-275 and Correlation with Histone Hyperacetylation
  Clinical Cancer Research, 2004
• Epidermal growth factor receptor and tumor response to radiation: in vivo preclinical studies
  International Journal of Radiation Oncology*Biology*Physics, 2004
• Enhanced Radiation-Induced Cell Killing and Prolongation of γH2AX Foci Expression by the Histone Deacetylase Inhibitor MS-275
  Cancer Research, 2004
• The RAS signal transduction pathway and its role in radiation sensitivity
  Oncogene, 2003
• A phase I trial of Depsipeptide (FR901228) in patients with advanced cancer
  Journal of Experimental Therapeutics and Oncology, 2002
• Sensing and repairing DNA double-strand breaks
  Carcinogenesis: Integrative Cancer Research, 2002
• Modulation of p53, ErbB1, ErbB2, and Raf-1 Expression in Lung Cancer Cells by Depsipeptide FR901228
  JNCI Journal of the National Cancer Institute, 2002
• Histone-deacetylase inhibitors: novel drugs for the treatment of cancer
  Nature Reviews Drug Discovery, 2002
• Histone deacetylases and cancer: causes and therapies
  Nature Reviews Cancer, 2001
• Antisense Inhibition of the RAD51 Enhances Radiosensitivity
  Biochemical and Biophysical Research Communications, 1996